Lilly Toker

4.9k citations

19 papers · 4.0k indexed · 2 hit papers · h-index 13

Pharmacology top 0.2%
Molecular Biology top 5%
Computational Theory and Mathematics top 0.2%
Organic Chemistry top 2%
Plant Science top 2%

Co-authors: Israel Silman Joel L. Sussman Michal Harel Felix Frolow Adrian Goldman Christian Oefner Dan S. Tawfik Leonid Gaidukov
Topics: Cholinesterase and Neurodegenerative Diseases (8 papers)Computational Drug Discovery Methods (6 papers)Paraoxonase enzyme and polymorphisms (4 papers)
Cited by: Pharmacology Clinical Biochemistry Computational Theory and Mathematics
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Israel France United States

In The Last Decade

Lilly Toker

19 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein

1991 2.2k citations Joel L. Sussman, Michal Harel et al. Science profile →
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

2004 501 citations Michal Harel, Amir Aharoni et al. Nature Structural & Molecular Biology profile →

Peers

Countries citing papers authored by Lilly Toker

Since Specialization

Citations

This map shows the geographic impact of Lilly Toker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilly Toker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilly Toker more than expected).

Fields of papers citing papers by Lilly Toker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilly Toker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilly Toker. The network helps show where Lilly Toker may publish in the future.

Co-authorship network of co-authors of Lilly Toker

This figure shows the co-authorship network connecting the top 25 collaborators of Lilly Toker. A scholar is included among the top collaborators of Lilly Toker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilly Toker. Lilly Toker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Polyproline-rich peptides associated with Torpedo californica acetylcholinesterase tetramers 2020 ·Chemico-Biological Interactions ·Lilly Toker,Israel Silman,Tzviya Zeev‐Ben‐Mordehai,Joel L. Sussman,Lawrence M. Schopfer,Oksana Lockridge	2
2	The Quaternary Structure of Amalgam, a Drosophila Neuronal Adhesion Protein, Explains Its Dual Adhesion Properties 2009 ·Biophysical Journal ·Tzviya Zeev‐Ben‐Mordehai,Efstratios Mylonas,Aviv Paz,Yoav Peleg,Lilly Toker,Israel Silman,Dmitri I. Svergun,Joel L. Sussman	10
3	Directed Evolution of Serum Paraoxonase PON3 by Family Shuffling and Ancestor/Consensus Mutagenesis, and Its Biochemical Characterization 2009 ·Biochemistry ·Olga Khersonsky,Mira Rosenblat,Lilly Toker,Shiri Yacobson,(unknown),Israel Silman,Joel L. Sussman,Michael Aviram,Dan S. Tawfik	35
4	Crystallographic Snapshots of Nonaged and Aged Conjugates of Soman with Acetylcholinesterase, and of a Ternary Complex of the Aged Conjugate with Pralidoxime 2009 ·Journal of Medicinal Chemistry ·Benoît Sanson,Florian Nachon,Jacques‐Philippe Colletier,Marie‐Thérèse Froment,Lilly Toker,Harry M. Greenblatt,Joel L. Sussman,(unknown),Patrick Masson,Israel Silman,Martin H. Weik	76
5	Amalgam, an axon guidance Drosophila adhesion protein belonging to the immunoglobulin superfamily: Over-expression, purification and biophysical characterization 2008 ·Protein Expression and Purification ·Tzviya Zeev‐Ben‐Mordehai,Aviv Paz,Yoav Peleg,Lilly Toker,Sharon G. Wolf,Edwin H. Rydberg,Joel L. Sussman,Israel Silman	9
6	Acid β-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy 2008 ·Biological Chemistry ·(unknown),Boris Brumshtein,Swetlana Boldin‐Adamsky,Lilly Toker,Alla Shainskaya,Israel Silman,Joel L. Sussman,Anthony H. Futerman	37
7	3-D Structure of Serum Paraoxonase 1 Sheds Light on Its Activity, Stability, Solubility and Crystallizability 2007 ·Archives of Industrial Hygiene and Toxicology ·Michal Harel,Boris Brumshtein,Ran Meged,Hay Dvir,Raimond B. G. Ravelli,Andrew A. McCarthy,Lilly Toker,Israel Silman,Joel L. Sussman	27
8	X-ray Structure of Human Acid-β-Glucosidase Covalently Bound to Conduritol-B-Epoxide 2005 ·Journal of Biological Chemistry ·Lakshmanane Premkumar,Anu R. Sawkar,Swetlana Boldin‐Adamsky,Lilly Toker,Israel Silman,Jeffery W. Kelly,Anthony H. Futerman,Joel L. Sussman	95
9	Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymesbreakdown → 2004 ·Nature Structural & Molecular Biology ·Michal Harel,Amir Aharoni,Leonid Gaidukov,Boris Brumshtein,Olga Khersonsky,Ran Meged,Hay Dvir,Raimond B. G. Ravelli,Andrew A. McCarthy,Lilly Toker,Israel Silman,Joel L. Sussman,Dan S. Tawfik	501
10	The intracellular domain of the Drosophila cholinesterase‐like neural adhesion protein, gliotactin, is natively unfolded 2003 ·Proteins Structure Function and Bioinformatics ·Tzviya Zeev‐Ben‐Mordehai,Edwin H. Rydberg,(unknown),Lilly Toker,Vanessa J. Auld,Israel Silman,Simone Botti,Joel L. Sussman	49
11	X‐ray structure of human acid‐β‐glucosidase, the defective enzyme in Gaucher disease 2003 ·EMBO Reports ·Hay Dvir,Michal Harel,Andrew A. McCarthy,Lilly Toker,Israel Silman,Anthony H. Futerman,Joel L. Sussman	217
12	Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization 2003 ·Proceedings of the National Academy of Sciences ·Amir Aharoni,Leonid Gaidukov,(unknown),Lilly Toker,Israel Silman,Dan S. Tawfik	234
13	Histochemical method for characterization of enzyme crystals: application to crystals ofTorpedo californicaacetylcholinesterase 2001 ·Acta Crystallographica Section D Biological Crystallography ·Anne Nicolas,François Ferrón,Lilly Toker,Joel L. Sussman,Israel Silman	2
14	Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II 2000 ·Acta Crystallographica Section D Biological Crystallography ·Gitay Kryger,Michal Harel,Kurt Giles,Lilly Toker,Baruch Velan,Arie Lazar,Chanoch Kronman,Dov Barak,Naomi Ariel,Avigdor Shafferman,Israel Silman,Joel L. Sussman	263
15	Acetylcholinesterase from Schistosoma mansoni: interaction of globular species with heparin 1999 ·Biochemical Journal ·Rebeca Tarrab‐Hazdai,Lilly Toker,Israel Silman,Ruth Arnon	7
16	Effect of heat shock on acetylcholinesterase activity in chick muscle cultures 1991 ·FEBS Letters ·Jerry Eichler,Lilly Toker,Israel Silman	7
17	Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Proteinbreakdown → 1991 ·Science ·Joel L. Sussman,Michal Harel,Felix Frolow,Christian Oefner,Adrian Goldman,Lilly Toker,Israel Silman	2244
18	Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C 1988 ·Journal of Molecular Biology ·Joel L. Sussman,Michal Harel,Felix Frolow,(unknown),Lilly Toker,Anthony H. Futerman,Israel Silman	92
19	Microtiter assay for acetylcholinesterase 1987 ·Analytical Biochemistry ·Bhupendra P. Doctor,Lilly Toker,Esther Roth,Israel Silman	100

About Lilly Toker

Lilly Toker is a scholar working on Clinical Biochemistry, Biochemistry and Pharmacology, having authored 19 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (8 papers), Computational Drug Discovery Methods (6 papers) and Paraoxonase enzyme and polymorphisms (4 papers). The work is most often cited by research in Pharmacology (2.3k citations), Clinical Biochemistry (556 citations) and Computational Theory and Mathematics (1.3k citations). Lilly Toker has collaborated with scholars based in Israel, France and United States. Frequent co-authors include Israel Silman, Joel L. Sussman, Michal Harel, Felix Frolow, Adrian Goldman, Christian Oefner, Dan S. Tawfik, Leonid Gaidukov, Amir Aharoni and Hay Dvir. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact